Patheon (PTI-T) Stock Predictions - Stockchase
WATCH LIST
194
Patheon (PTI-T)

ON STOCKCHASE SINCE Nov 2000

Drug outsourcing

Acquired by JLL/ Patheon Holdings (March 2014)

biotechnology/pharmaceutical

Patheon

PTI-T

6 watching          
Join the Discussion

Patheon (PTI-T) SAVE Dec, 31, 1969, 7:00 pm

0.00 0 (100%)

This company is not ACTIVE.

What the experts are saying about PTI-T



  • All
  • Filtered
Signal Opinion Expert
COMMENT
Patheon(PTI-T) 

June 21, 2013

Rates this as C+ in his system, but is probably going to have to upgrade that. Revenue is starting to accelerate. Have a new management team on board that is basically focusing the company and going for profitable business, instead of just doing acquisitions. Last quarter was very, very solid. Stock is up 174% in this last year and is starting to get noticed again.

biotechnology/pharmaceutical
0 0 0 0 0
0 comments

Rates this as C+ in his system, but is probably going to have to upgrade that. Revenue is starting to accelerate. Have a new management team on board that is basically focusing the company and going for profitable business, instead of just doing acquisitions. Last quarter was very, very solid. Stock is up 174% in this last year and is starting to get noticed again.

biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Peter Hodson

CEO & Head, 5i Research Inc....

Price Price
$5.740
Owned Owned
No

SELL
Patheon(PTI-T) 

May 2, 2011

Low margin business and has been decimated over time. Sees nothing that would tempt him to Buy. If you own, consider selling and moving on to something else.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Low margin business and has been decimated over time. Sees nothing that would tempt him to Buy. If you own, consider selling and moving on to something else.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
John Zechner

Chairman, J. Zechner & Assoc...

Price Price
$2.200
Owned Owned
No

COMMENT
Patheon(PTI-T) 

June 18, 2009

Had some challenges over the last few years. Recently been on a recovery path of straightening out operations and lowering costs. There has been an unsolicited takeover bid. Need to continue executing on their current strategy. Worth a look.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Had some challenges over the last few years. Recently been on a recovery path of straightening out operations and lowering costs. There has been an unsolicited takeover bid. Need to continue executing on their current strategy. Worth a look.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Jim Huang

President, T.I.P. Wealth Manage...

Price Price
$2.740
Owned Owned
No

HOLD
Patheon(PTI-T) 

November 18, 2008

(Market Call Minute.) You have to be careful of them, as they have had execution issues over time.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
(Market Call Minute.) You have to be careful of them, as they have had execution issues over time.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Duncan Stewart

Director o, DSAM Consulting...

Price Price
$0.980
Owned Owned
No

COMMENT
Patheon(PTI-T) 

November 7, 2008

Relatively risky but the company has made a lot of the right moves. Grew very fast but like a lot of companies, had problems with some of their acquisitions. Have a pretty high cost structure. Thinks the worst is over. On a five-year timeframe, the trend for outsourcing is still there.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Relatively risky but the company has made a lot of the right moves. Grew very fast but like a lot of companies, had problems with some of their acquisitions. Have a pretty high cost structure. Thinks the worst is over. On a five-year timeframe, the trend for outsourcing is still there.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Peter Hodson

CEO & Head, 5i Research Inc....

Price Price
$1.880
Owned Owned
No

HOLD
Patheon(PTI-T) 

July 8, 2008

(Market call minute.) New management. Closing operations. In a turn around phase.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
(Market call minute.) New management. Closing operations. In a turn around phase.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Peter Hodson

CEO & Head, 5i Research Inc....

Price Price
$4.240
Owned Owned
Unknown

DON'T BUY
Patheon(PTI-T) 

December 20, 2007

(Market Call Minute.) Model price is $2.75, a -13% differential.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
(Market Call Minute.) Model price is $2.75, a -13% differential.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Brian Acker, CA

Chief Exec, Acker Finley Inc....

Price Price
$3.200
Owned Owned
No

COMMENT
Patheon(PTI-T) 

December 13, 2007

Made a big acquisition about 2 years ago, which basically almost blew the company up. There were a lot of money-losing contracts that they have been trying to clean up. Eventually it will probably turn around, but the question is will they get it done in 08 or 09.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Made a big acquisition about 2 years ago, which basically almost blew the company up. There were a lot of money-losing contracts that they have been trying to clean up. Eventually it will probably turn around, but the question is will they get it done in 08 or 09.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Alex Ruus

Portfolio , Arrow Capital Manage...

Price Price
$3.300
Owned Owned
No

PAST TOP PICK
Patheon(PTI-T) 

August 17, 2007

(Top Short) Then 5.50 Had a premium valuation that they no longer deserved. He shorted and it paid for him. It's going to be a long hard turn around.

biotechnology/pharmaceutical
0 0 0 0 0
0 comments

(Top Short) Then 5.50 Had a premium valuation that they no longer deserved. He shorted and it paid for him. It's going to be a long hard turn around.

biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Peter Hodson

CEO & Head, 5i Research Inc....

Price Price
$3.450
Owned Owned
Unknown

PAST TOP PICK
Patheon(PTI-T) 

June 13, 2007

Then 5.95 Stop loss at 5 20. If a stock goes below the stop loss, then if it doesn't recover within a week, it's time to move on. Don't buy right now. Bottom fishing.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Then 5.95 Stop loss at 5 20. If a stock goes below the stop loss, then if it doesn't recover within a week, it's time to move on. Don't buy right now. Bottom fishing.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Bill Carrigan

Technical , Getting Technical In...

Price Price
$4.020
Owned Owned
Unknown

SELL
Patheon(PTI-T) 

March 16, 2007

Big disappointment to investors. Doesn’t see any prospects for an immediate recovery. Earnings forecasts for the next year or so are only in the $.20 range.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Big disappointment to investors. Doesn’t see any prospects for an immediate recovery. Earnings forecasts for the next year or so are only in the $.20 range.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Michael Sprung

President, Sprung Investment Ma...

Price Price
$4.500
Owned Owned
No

DON'T BUY
Patheon(PTI-T) 

February 7, 2007

This was one of her most successful Shorts last year. Would not be a buyer.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
This was one of her most successful Shorts last year. Would not be a buyer.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Veronika Hirsch

Chief Inve, Arrow Capital...

Price Price
$5.260
Owned Owned
No

PAST TOP PICK
Patheon(PTI-T) 

February 1, 2007

(A Top Pick Aug 11/06. Down 8.1%.) It is probably at the bottom of a trading range and it will probably work up to the upper band.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
(A Top Pick Aug 11/06. Down 8.1%.) It is probably at the bottom of a trading range and it will probably work up to the upper band.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Bill Carrigan

Technical , Getting Technical In...

Price Price
$5.390
Owned Owned
Unknown

DON'T BUY
Patheon(PTI-T) 

January 8, 2007

This is not a stock that you want to look at. It couldn't rally with The market that we had over the last 4 years. A bottom fish play.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
This is not a stock that you want to look at. It couldn't rally with The market that we had over the last 4 years. A bottom fish play.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
David Burrows

President , Barometer Capital Ma...

Price Price
$4.920
Owned Owned
No

DON'T BUY
Patheon(PTI-T) 

November 9, 2006

A beat up company that deserves to be beaten up. Porto Rico acquisition turned extremely sour. Have had a revolving door in the executive office. Large debt.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
A beat up company that deserves to be beaten up. Porto Rico acquisition turned extremely sour. Have had a revolving door in the executive office. Large debt.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
David Driscoll

President , Liberty Internationa...

Price Price
$5.300
Owned Owned
No

Showing 1 to 15 of 194 entries
Successfully Saved Company
Successfully Saved Company
0+
JOIN THE DISCUSSION
0 comments in the last 7 days